Hope and Help For Fatigue & Chronic Illness EP39: Immunotherapy: The Future of Cancer Treatment
Apply for Treatment at Immunocine: https://immunocine.com/patient-intake/
In this episode, Haylie Pomroy sits down with Dr. Matthew Halpert of Immunocine Cancer Center, an expert in immunotherapy and cancer research.
Together, they explore how immunotherapy teaches the immune system to recognize and fight cancer more effectively, offering a targeted approach with fewer side effects compared to traditional treatments like chemotherapy and radiation.
Dr. Halpert explains the key role dendritic cells play in the immune system and how Immunocine is using this knowledge to develop personalized cancer treatments. They also discuss the importance of early intervention and how personalized care can make a significant difference in cancer outcomes.
Whether you're looking for new treatment options or want to learn more about the future of cancer care, this episode offers valuable insights into how immunotherapy can provide hope and help for every cancer patient.
Tune in to the latest episode of the Hope and Help for Fatigue and Chronic Illness Podcast – Immunotherapy: The Future of Cancer Treatment
Did you like this episode? Watch out for Dr. Matthew Halpert’s next appearance on the podcast with one of his patients. Subscribe to the channel so you won’t miss any updates!
Did you like this episode? Watch out for Dr. Matthew Halpert’s next appearance on the podcast with one of his patients. Subscribe to the channel so you won’t miss any updates!
Immunocine Testimonials: https://immunocine.com/testimonials/
Learn more about INIM’s Research Studies:
https://www.nova.edu/nim/research-studies/index.html
If you are interested in joining a Gulf War Illness (GWI) trial, please complete the Recruitment Registry Form.
Donate to ME/CFS Research: https://givecampus.com/b3yrwb
Sign up for the COVID-UPP Study:
Dr. Matthew Halpert, a PhD graduate in Microbiology and Immunology from the University of Alabama at Birmingham (UAB), spent 10 years at Baylor College of Medicine as a leading Cancer Immunologist. His groundbreaking work in cancer immunotherapy has been widely published and cited over 450 times. Dr. Halpert founded Diakonos Oncology, pioneering Dendritic Cell Treatment, which is currently in FDA clinical trials, including a "Fast Track" Glioblastoma trial. In 2021, he established the ImmunoCine Cancer Center to provide immediate access to this innovative treatment for patient’s ineligible for trials.
Instagram: https://instagram.com/matthalpertphd
https://instagram.com/immunocine
Facebook - https://www.facebook.com/people/Matt-Halpert/100079347564008/
https://www.facebook.com/Immunocine
X- https://x.com/Matthalpertphd
Website: https://immunocine.com
-------------------------------------------------------------------------------------------------
Enjoy our show? Please leave us a 5-star review so we can bring hope and help to others.
Sign up today for our newsletter.
https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d
This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here.
Website: https://www.nova.edu/nim/
Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine
Instagram: https://www.instagram.com/NSU_INIM/
Twitter: https://www.twitter.com/NSU_INIM
#CancerCare #Immunotherapy #HealthInnovation #Cancer #ChronicIllness #Healthcare #CancerTreatment #Immunocine #CancerResearch #MedicalResearch #ClinicalResearch #EarlyIntervention #HealthPodcast